By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    medicare part d benefits
    Everything that You Need to Know About Medicare Part D
    August 15, 2022
    Best Ways to Boost Your Immune System this Winter
    Best Ways to Boost Your Immune System this Winter
    November 15, 2022
    back pain issues
    Ways to Treat Constant Back Pain
    August 21, 2023
    Latest News
    How Probate Planning Shapes the Future of Your Estate and Family Care
    July 17, 2025
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
    The Best Home Remedies for Migraines
    June 5, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    More On Wellness Programs To Improve Health and Reduce Costs
    January 25, 2012
    Privatizing Social Security and Medicare: Who Can Defuse Political Dynamite?
    June 12, 2011
    Study: Risk of Death in Elderly Patients with Dementia Doubled with Some Antipsychotic Medications
    February 26, 2012
    Latest News
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
    How Health Choices and Legal Actions Intersect After an Injury
    July 17, 2025
    How communities and healthcare providers can address slip and fall injuries with legal awareness
    July 17, 2025
    Let Your Lawyer Handle the Work Before You Pay Medical Costs
    July 6, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Personalized Medicine: Reimbursement and Marketing Challenges
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > eHealth > Social Media > Personalized Medicine: Reimbursement and Marketing Challenges
Social Media

Personalized Medicine: Reimbursement and Marketing Challenges

David Avitabile
David Avitabile
Share
4 Min Read
SHARE

personalized_medicineWe are undoubtedly in the midst of major change in how healthcare is delivered, measured and paid for. As with all periods of great change, there are going to be winners and losers. One area I’ve been bullish about for a few years now is diagnostics and personalized medicine.

personalized_medicineWe are undoubtedly in the midst of major change in how healthcare is delivered, measured and paid for. As with all periods of great change, there are going to be winners and losers. One area I’ve been bullish about for a few years now is diagnostics and personalized medicine. As the US healthcare system moves from a volume based model to a value and outcomes based model, the ability to deliver the right treatment to the right patient at the right time means that personalized medicine, and the diagnostic products and services that make it possible, has an opportunity to be a real winner. The growth statistics and forecasts for this dynamic market sector make for interesting reading.

Diagnostics marketing faces key challenges in today’s healthcare environment however. Perhaps the biggest of these is in communicating value so that reimbursement decision makers understand the cost savings and patient outcomes improvements that many of these technologies offer. One of the keys to overcoming this challenge, I believe, is to position personalized medicine and diagnostics within the context of evidence-based medicine. This has been an area of some debate since “personalized medicine” emerged as part of the medical lexicon. Some practitioners rooted in evidence-based medicine, with its focus on large scale randomized clinical trials, saw personalized medicine as a competitor to the evidence-based model. I believe that is a misperception and a communications challenge. And as any good marketer knows, poor communication can lead to and misperceptions. And misperceptions can destroy good products. Diagnostics contribute to the overall body of evidence available to physicians. It is another decision making tool in the arsenal of good medical practice.

In terms of research and development of new drugs, the integration of companion diagnostics into clinical trials for new treatments of all kinds holds the promise of helping to make clinical development more efficient. And with recent news about the cost of bringing a drug to market — $2.6 billion according to the Tufts Center for the Study of Drug Development — anything that has the potential to identify failures early, streamline the process, reduce clinical development timelines and bring new treatments to market faster simply cannot be ignored.

More Read

A Garden of HealthCare Phone Apps – Watch it Grow
LifeLongHealth.com – A Health-Oriented Social Network for Baby Boomers
Diabetes and Oncology at Doctors 2.0 & You
Should Government Control Big Pharma Marketing?
The difference between doctors, patients and campaigns

Once seen as separate silos in the life sciences ecosystem, the fact is that today the pharmaceutical industry needs diagnostic technologies as an integral part of their approach to developing new treatments and evaluating their efficacy.

Reimbursement for these technologies remains challenging. Marketers have a key role to play here, as do clinical development teams at the companies developing diagnostic products and services. Communicating the value of of a test that costs (for argument’s sake) $3,500 can be challenging without compelling messaging supported by data. But effectively communicating how that $3,500 test could save $60,000 per year on a chemotherapy that is not going to work for that specific patient puts cost and value into a completely different framework, and allows for constructive engagement between the diagnostic innovator and reimbursement authorities.

Periods of great change often come with great challenges. Effective marketing and communications can be just as important to commercial success as clinical data and outcomes.

 

Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
How IT and Marketing Teams Can Collaborate to Protect Patient Trust
Global Healthcare Policy & Law
July 17, 2025
paramedics in surgical gloves and masks
How Health Choices and Legal Actions Intersect After an Injury
Health care
July 16, 2025
a woman giving a key
How Probate Planning Shapes the Future of Your Estate and Family Care
Health
July 16, 2025
a woman with kinesio tapes on her back arm
How communities and healthcare providers can address slip and fall injuries with legal awareness
Health care
July 16, 2025

You Might also Like

Social Media

How Physicians Can Adopt Social Media (Before It’s Too Late)

April 18, 2013
digital-analytics-101-blogging
BusinesseHealthSocial Media

Digital Analytics 101 for Healthcare Marketers: Blogging

March 10, 2016

Epion Health Introduces A Tablet To Increase Health Literacy

June 9, 2012

Getting Young Invincibles to Buy Health Insurance?

March 16, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?